Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MODIFICATION TO BIOMARC TISSUE MARKER

K-Number: K063193 · 2006-11-21

ApplicantCarbon Medical Technologies, Inc.
Decision Date2006-11-21
Product CodeNEU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

MODIFICATION TO BIOMARC TISSUE MARKER is the device name listed in this FDA 510(k) record. The listed applicant is Carbon Medical Technologies, Inc.. It received FDA 510(k) clearance on 2006-11-21 under 510(k) number K063193. The device is classified under product code NEU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MODIFICATION TO BIOMARC TISSUE MARKER?

MODIFICATION TO BIOMARC TISSUE MARKER is a medical device that received FDA 510(k) clearance on 2006-11-21. The listed applicant is Carbon Medical Technologies, Inc.. The 510(k) number is K063193.

When did MODIFICATION TO BIOMARC TISSUE MARKER receive FDA 510(k) clearance?

MODIFICATION TO BIOMARC TISSUE MARKER received FDA 510(k) clearance on 2006-11-21, under 510(k) number K063193.

Who is the listed applicant for MODIFICATION TO BIOMARC TISSUE MARKER?

The FDA 510(k) record lists Carbon Medical Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MODIFICATION TO BIOMARC TISSUE MARKER?

The FDA product code for MODIFICATION TO BIOMARC TISSUE MARKER is NEU.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Carbon Medical Technologies, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253598InjecSURE Injection SystemK251748MammoSTAR Biopsy Site IdentifierK211590Fiducial MarkerK172227Endoscopic Injection NeedleK132708BIOMARC FIDUCIAL MARKERK130678BIOMARC GOLD FIDUCIAL MARKER

View all 15 devices →

Related Devices (Code: NEU)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253761HydroMARK™ Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK™ Plus Breast Biopsy Site Marker (Hummingbird Shape)Devicor Medical Products, Inc.K253888MOLLI 2 SystemStryker EndoscopyK252892SCOUT MD Surgical Guidance SystemMerit Medical Systems, Inc.K251989VizMark Preloaded Tissue Marker Device (VM-0001)Breast-Med, Inc.K251748MammoSTAR Biopsy Site IdentifierCarbon Medical Technologies, Inc.K243642UltraCor™ Twirl™ Breast Tissue MarkerBard Peripheral Vascular, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑